Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | White Papers
Search Refinements

Contract Research White Papers

View white papers from other Pharmaceutical sectors:
121-135 of 166 results
Introduction of Pierre de Meyts. MD, PhD, F.A.C.E
| By Novo Nordisk Pharmatech A/S
Pierre de Meyts is an expert who has worked with and researched insulin and receptor binding for almost half a century. FeF Chemicals A/S is proud to present what we assume to be one of the best pieces describing the functionality of insulin and insulin like growth factors, with respect to receptor binding and cellular response.
Contract Research & Services > Contract Research > White Papers
SOLUTIONS IN QUATS THAT FIT YOUR REQUIREMENTS cGMP Pharmaceutical Grade APIs & Excipients
| By Novo Nordisk Pharmatech A/S
FeF Chemicals is the worldwide leading supplier of high quality Quaternary Ammonium Compounds (quats). We are specialized in the pharmaceutical and personal care industries, providing quats of global regulatory compliance. We provide only the very best and safest ingredients for your formulation, preserving its quality and contributing to patient safety.
Contract Research & Services > Contract Research > White Papers
ePRO Helps Sponsors Deliver a More Patient-Centric Study
| By CRF Health
There is now a greater demand for patient input during clinical research, with many more clinical studies collecting patientreported outcome (PRO) data.
Contract Research & Services > Contract Research > White Papers
PSN Brochure
| By PSN
psn is a full-service global Contract Research Organization (CRO) with over 200 employees in 11 offices across Northern America and Europe. We offer superior clinical development services to biotechnology, pharmaceutical companies and independent institutions acting as sponsors who wish to have a dedicated and cost effective partner.
Contract Research & Services > Contract Research > White Papers
Reagents for Fine Organic Synthesis – Building Blocks
| By Enamine
Renowned for supply of quality screening compound libraries, Enamine, a globally operating medicinal chemistry driven CRO, has developed the world’s largest catalogue of in-house designed and synthesized Building Blocks to complement its large offering of products for early stage drug discovery projects. The company pioneered the Building Block market in the early 2000’s capitalizing on its increasing chemistry experience and the growing number of Building Blocks it had synthesized for library design and numerous synthesis programs.
Contract Research & Services > Contract Research > White Papers
Pre-Packaged Diversity Sets of Compounds for Screening
| By Enamine
Built on pharmacological profile of compounds rather than on their chemical structure Pharmacological Diversity Set is a brand new tool for HTS campaigns.
Contract Research & Services > Contract Research > White Papers
Collection of Compounds for High-Throughput Screening
| By Enamine
Enamine’s collection of 1.8 million screening compounds is the world’s largest and most reputable source of small molecules for drug discovery. The majority of the compounds have been synthesized in-house within last 10 years. Each year ca. 200,000 new compounds are added to our collection making it always fresh and interesting for the search of new leads.
Contract Research & Services > Contract Research > White Papers
In-Stock-Tomorrow Tangible Structures – REAL Database
| By Enamine
REAL DataBase (RDB) is the array of 16 million feasible diverse drug-like structures. The compounds are synthesized in only 1 step using thoroughly protocolled chemical procedures from available building blocks.
Contract Research & Services > Contract Research > White Papers
Library of Compounds for Fragment-Based Drug Design
| By Enamine
The fragment-based approach to drug discovery (FBDD) has been established as an efficient tool in the search for new drugs.1,2 It has been often used since the late 1990s.3 Nowadays a few compounds discovered by FBDD are entering the clinic.4 FBDD has emerged as an alternative approach to traditional lead identification via high-throughput screening (HTS).
Contract Research & Services > Contract Research > White Papers
Pharmacological Diversity Set and 3D Diversity Set
| By Enamine
Three-dimensional shape is an essential property of molecules determining their principal ability to bind to biological targets. To maximize biological relevance of a compound library we sought to use this fundamental property in combination with other design approaches.
Contract Research & Services > Contract Research > White Papers
121-135 of 166 results